Related Experiment Video
Updated: Oct 23, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Bleeding avoidance strategies in percutaneous coronary intervention
Davide Capodanno1, Deepak L Bhatt2, C Michael Gibson3
1Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy.
Minimizing bleeding in percutaneous coronary intervention (PCI) is crucial, as bleeding is a significant negative prognostic factor. New strategies focus on enhancing safety alongside efficacy for antithrombotic treatments and procedures.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Historically, bleeding was accepted as a necessary risk of percutaneous coronary intervention (PCI) to prevent thrombotic events.
- Bleeding is now recognized as a major adverse event, impacting patient prognosis similarly to ischemic complications.
Purpose of the Study:
- To review current data and strategies for minimizing bleeding in patients undergoing PCI.
- To highlight the shift in perspective recognizing bleeding as a critical prognostic factor.
Main Methods:
- Review of contemporary data on bleeding avoidance in PCI.
- Discussion of risk stratification and procedural/pharmacological strategies.
- Analysis of pretreatment, vascular access, stent selection, and antithrombotic regimens.
Main Results:
- Bleeding is a significant negative prognostic indicator in PCI, comparable to thrombotic events.
- A paradigm shift necessitates a focus on safety alongside efficacy in PCI treatments.
- Various strategies can be employed to minimize bleeding risk.
Conclusions:
- Optimizing safety by minimizing bleeding is a key goal in PCI.
- Comprehensive strategies encompassing risk assessment and tailored interventions are essential for effective bleeding avoidance.
- Future PCI approaches must balance antithrombotic efficacy with improved patient safety.
More Related Videos
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

